This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Zhejiang University. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Xinjian Yin: Innovator in Glutamate Dehydrogenase Mutants
Introduction
Xinjian Yin is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of biochemistry, particularly in the development of glutamate dehydrogenase mutants. With a total of 2 patents, his work has implications for various applications in biotechnology.
Latest Patents
Xinjian Yin's latest patents include innovations related to glutamate dehydrogenase mutants. One patent discloses a glutamate dehydrogenase mutant that improves catalytic activity through molecular transformation methods. This invention addresses the low activity of glutamate dehydrogenase in the preparation of L-glufosinate by reductive amination. Another patent focuses on the application of glutamate dehydrogenase mutants in the preparation of L-phosphinothricin. By utilizing molecular engineering techniques, he has developed NADPH-specific and NADH-specific glutamate dehydrogenase mutants that significantly enhance substrate conversion and product concentration.
Career Highlights
Xinjian Yin is affiliated with Zhejiang University, where he conducts his research and development. His work has garnered attention in the scientific community for its innovative approach to enzyme engineering. His contributions have the potential to advance the field of biochemistry and biotechnology.
Collaborations
Xinjian Yin collaborates with notable colleagues, including Jianping Wu and Gang Xu. Their combined expertise fosters a productive research environment that enhances the development of innovative solutions in their field.
Conclusion
Xinjian Yin is a distinguished inventor whose work on glutamate dehydrogenase mutants has the potential to revolutionize applications in biotechnology. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and practical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
